PJ, December 2024, Vol 313, No 7992

Approval of new NHS drugs results in population health ‘trade-offs’, study results suggest

Study authors concluded that the use of new drugs on the NHS resulted in an additional cost of more than £75bn between 2000 and 2020.…

Pharmacy contract negotiations to start in new year, says health secretary

Speaking at an evidence session held by the Health and Social Care Committee, Wes Streeting said his main focus was on “stabilising the system”.…

Looking back at 2024: a review of the biggest stories in pharmacy

In this episode, The PJ team revisits 2024 in pharmacy before sharing predictions for the year ahead.…

Government advises ICBs set up local plans to address PERT supply shortages

The supply shortage impacts three pancreatic enzyme replacement therapy products: Creon (Viatris) 10,000 and 25,000 capsules, Nutrizym 22 (Zentiva) capsules and Pancrex V (Essential Pharma) capsules and powder.…

MHRA eliminates backlog of medicines awaiting marketing authorisation

After resolving its backlog of medicines approvals, the Medicines and Healthcare products Regulatory Agency aims to adopt its tailored biosimilar UK licensing pathway as it does not need manufacturers to conduct confirmatory clinical trials.…

PJ view: There are still reasons to be optimistic about pharmacy in 2025, despite a challenging 2024

A turbulent 2024 has left the pharmacy profession with many uncertainties, but there are still opportunities to come in 2025.…

Supporting palliative and end-of-life care in Welsh community pharmacies: a pilot study

The demand for palliative and end-of-life care in Wales is projected to almost double by 2040, increasing from 25% to 47%1. This underscores the increasing importance of community pharmacies in supporting patients with life-limiting illnesses. Palliative and end-of-life care is vital because i…

Working across boundaries to enable research in pharmacy

A snapshot of the research presented at the Royal Pharmaceutical Society’s 2024 Annual Conference, by deputy chief scientist Diane Ashiru-Oredope.…

Pharmacy First treatment options should be broadened to support antimicrobial stewardship, says CCA

The Company Chemists’ Association says widening treatment options for conditions under the Pharmacy First service would “ensure antibiotics are only provided when absolutely required”.…